SAN
FRANCISCO, Oct. 30, 2024 /PRNewswire/ --
Schubert Jonckheer & Kolbe LLP advises Verrica
Pharmaceuticals Inc. investors that the firm is investigating
potential legal claims relating to the company's unsuccessful
efforts in 2021 and 2022 to secure regulatory approval for its drug
product VP-102, designed to treat molluscum. Current shareholders
are encouraged to contact the firm.
On September 3, 2024, Chief Judge
Mitchell S. Goldberg of the U.S.
District Court for the Eastern District of Pennsylvania issued an order denying in part a
motion to dismiss a class action complaint filed against Verrica
and certain of its executive officers. There, it is
alleged that dermatology therapeutics company Verrica
intentionally misled investors between May
2021 and May 2022 about the
prospects of obtaining U.S. Food and Drug Administration approval
for VP-102 (or YCANTH) by concealing known quality control problems
at its contract manufacturer. When the truth was revealed in
May 2022, Verrica's stock fell almost
64%.
The Schubert firm is investigating potential wrongdoing by
Verrica's officers and directors in connection with these
allegations.
If you own stock in Verrica and want additional information
about your legal rights, please visit our website at
https://www.classactionlawyers.com/verrica.
About Schubert Jonckheer & Kolbe LLP
Schubert
Jonckheer & Kolbe represents shareholders, employees, and
consumers in class actions against corporate defendants, as well as
shareholders in derivative actions against their officers and
directors. The firm is based in San
Francisco, and with the help of co-counsel, litigates cases
nationwide.
Contact
Dustin L.
Schubert
Schubert Jonckheer & Kolbe LLP
dschubert@schubertlawfirm.com
Tel: (415) 788-4220
View original
content:https://www.prnewswire.com/news-releases/verrica-pharmaceuticals-inc-investor-alert-nasdaq-vrca-schubert-jonckheer--kolbe-llp-investigating-potential-shareholder-claims-against-the-companys-officers-and-directors-for-possible-false-statements-302291125.html
SOURCE Schubert Jonckheer & Kolbe LLP
